Clinical Trial Record

Return to Clinical Trials

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients


2022-12-21


2025-11-22


2026-05


80

Study Overview

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are receiving chemotherapy.

N/A

  • Pancreatic Cancer
  • BEHAVIORAL: Consultations with Moffitt Dietician
  • BEHAVIORAL: Daily Food Intake Diary with Fitbit Smartphone application
  • BEHAVIORAL: Questionnaires
  • MCC-22082

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2022-12-09  

N/A  

2025-07-31  

2022-12-21  

N/A  

2025-08-01  

2023-01-09  

N/A  

2025-07  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: Group 1: STRONG Intervention

The STRONG program includes consultation with a Moffit dietician, logging intake of food daily into a food diary with a Fitbit smartphone app, and completing questionnaires.

BEHAVIORAL: Consultations with Moffitt Dietician

  • Participants will have an initial consultation and then biweekly follow-up visits (in-person or virtually) with a study dietician for 12 weeks.

BEHAVIORAL: Daily Food Intake Diary with Fitbit Smartphone application

  • Participants will keep a daily diary of food intake with a Fitbit smartphone app and wearing a Fitbit for 12 weeks.

BEHAVIORAL: Questionnaires

  • Participants will complete a questionnaire electronically at baseline and again at 4, 8, 12 and 16 weeks.
ACTIVE_COMPARATOR: Group 2: Usual Care

Participants will be referred to dieticians based on clinical discretion. Participants will also be asked to wear a Fitbit for 12 weeks to passively collect data on activity level.

BEHAVIORAL: Consultations with Moffitt Dietician

  • Participants will have an initial consultation and then biweekly follow-up visits (in-person or virtually) with a study dietician for 12 weeks.

BEHAVIORAL: Daily Food Intake Diary with Fitbit Smartphone application

  • Participants will keep a daily diary of food intake with a Fitbit smartphone app and wearing a Fitbit for 12 weeks.

BEHAVIORAL: Questionnaires

  • Participants will complete a questionnaire electronically at baseline and again at 4, 8, 12 and 16 weeks.
Primary Outcome MeasuresMeasure DescriptionTime Frame
Feasibility of the STRONG ProgramFeasibility of the Support through Remote Observation and Nutrition Guidance (STRONG) program will be assessed using recruitment and retention rates, along with data completion rates.at 12 weeks
Acceptability of the STRONG ProgramAcceptability of the STRONG Program measure uses 4 items to indicate participant satisfaction. The measure uses a scale of 0-5, 0 meaning the participant completely disagrees with the statements regarding intervention satisfaction and 5 indicating complete agreement with the statements regarding intervention satisfaction. The measure score ranges from 0-20 with 20 indicating the highest degree of satisfaction.at 16 weeks
Participant adherence to the STRONG Programwill be defined as ≥ 60% of patients will meet with a dietician for 4/6 dietician visits and ≥ 60% of patients will track daily food intake via a Fitbit.Up to 90 days
Malnutrition: Significant Weight LossSignificant weight loss will be defined as a loss of >5% and >10% of body weight over the 16 week assessment period. Weight will be measured in kg.at 16 weeks
Malnutrition: Low BMILow BMI will be calculated by combining weight (kg) and height measurements (m²) and defined as <20kg/m² for adults < 70 years old and <22kg/m² for adults ≥ 70 years old over the 16 week assessment period.at 16 weeks
Malnutrition: Low Skeletal Muscle MassLow skeletal muscle mass will be calculated by estimating skeletal muscle index (SMI) by dividing the cross-sectional area of muscle in a single 'slice' from an abdominal CT scan (cm2) by stature (square of height in m²). Low SMI will be defined as ≤38.9 cm2/m2 for females and ≤55.4 for males over the 16 week assessment period.at 16 weeks
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • 18 years of age or older
  • Diagnosed metastatic or newly recurrent pancreatic cancer or locally advanced pancreatic cancer
  • Receiving chemotherapy under the guidance of Moffitt
  • Able to speak and read English
  • Able to provide informed consent

  • Exclusion Criteria:

  • Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse).
  • Undergoing concurrent treatment for a second primary GI cancer
  • ECOG status of 2 or greater
  • Use of parenteral or enteral nutrition
  • Presence of malignant ascites

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Pancreatic Cancer Action Network

  • PRINCIPAL_INVESTIGATOR: Amir Alishahi Tabriz, MD, PhD, MPH, Moffitt Cancer Center

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Turner K, Kim DW, Gonzalez BD, Gore LR, Gurd E, Milano J, Riccardi D, Byrne M, Al-Jumayli M, de Castria TB, Laber DA, Hoffe S, Costello J, Robinson E, Chadha JS, Rajasekhara S, Hume E, Hagen R, Nguyen OT, Nardella N, Parker N, Carson TL, Tabriz AA, Hodul P. Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial. Contemp Clin Trials Commun. 2024 Feb 23;38:101271. doi: 10.1016/j.conctc.2024.101271. eCollection 2024 Apr.